For example, the high immunogenicity of a fully non-self-antigen such as rat-neu in the TUBO tumour bearing WT BALB/c model, will most likely result in overestimation of the potency of combining anti-neu mAb therapy with immunotherapy. Here, ERBB2 is linked to neoplasm.